Browse by UCL people
Group by: Type | Date
Number of items: 6.
2024
Degirmencay, Abdullah;
Thomas, Sharyn;
Holler, Angelika;
Burgess, Samuel;
Morris, Emma C;
Stauss, Hans J;
(2024)
Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function.
Frontiers in Immunology
, 15
, Article 1386132. 10.3389/fimmu.2024.1386132.
|
2023
|
Degirmencay, Abdullah;
Thomas, Sharyn;
Mohammed, Fiyaz;
Willcox, Benjamin E;
Stauss, Hans J;
(2023)
Modifications outside CDR1, 2 and 3 of the TCR variable β domain increase TCR expression and antigen-specific function.
Frontiers in Immunology
, 14
, Article 1148890. 10.3389/fimmu.2023.1148890.
|
 |
2019
|
Morris, EC;
Tendeiro-Rego, R;
Richardson, R;
Fox, TA;
Sillito, F;
Holler, A;
Thomas, S;
... Stauss, H; + view all
(2019)
A Phase I Study Evaluating the Safety and Persistence of Allorestricted WT1-TCR Gene Modified Autologous T Cells in Patients with High-Risk Myeloid Malignancies Unsuitable for Allogeneic Stem Cell Transplantation.
Presented at: 61st ASH Annual Meeting, Orlando, FL, USA.
|
|
Thomas, S;
Mohammed, F;
Reijmers, RM;
Woolston, A;
Stauss, T;
Kennedy, A;
Stirling, D;
... Stauss, HJ; + view all
(2019)
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function.
Nature Communications
, 10
(1)
, Article 4451. 10.1038/s41467-019-12441-w.
|
 |
2018
|
Bray, C;
Wright, D;
Haupt, S;
Thomas, S;
Stauss, H;
Zamoyska, R;
(2018)
Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2.
Frontiers in Immunology
, 9
, Article 2595. 10.3389/fimmu.2018.02595.
|
|
|
Khan, AB;
Carpenter, B;
Sousa, PSE;
Pospori, C;
Khorshed, R;
Griffin, J;
Veliça, P;
... Chakraverty, R; + view all
(2018)
Redirection to the bone marrow improves T cell persistence and antitumor functions.
The Journal of Clinical Investigation
, 128
(5)
pp. 2010-2024.
10.1172/JCI97454.
|
|
